FDA approves atezolizumab plus bevacizumab for ... | 合法醫療器材資訊網

FDA approves atezolizumab for first-line treatment of metastatic NSCLC with high ... On May 18, 2020, the Food and Drug Administration approved atezolizumab ... Read More

FDA approves atezolizumab for PD-L1 positive unresectable locally advanced or ... On March 8, 2019, the Food and Drug Administration granted accelerated ... Read More

2020年6月1日 — FDA approves atezolizumab plus bevacizumab for unresectable hepatocellular carcinoma ... On May 29, 2020, the Food and Drug Administration ... Read More

2021年1月28日 — Tecentriq FDA Approval History · Urothelial Carcinoma. Tecentriq is indicated for the treatment of adult patients with locally advanced or metastatic ... Read More

Patients with EGFR or ALK genomic tumor aberrations should have disease progression on FDA- approved therapy for NSCLC harboring these aberrations prior ... Read More

TECENTRIQ. TECENTRIQ® (atezolizumab) injection, for intravenous use ... should have disease progression on FDA-approved therapy for NSCLC harboring ... Read More

In October 2016, atezolizumab was approved by the FDA for the treatment of people with metastatic non-small cell lung cancer (NSCLC) whose disease ... Read More